Andrea Kunz

Managing Editor for the Journal for ImmunoTherapy of Cancer (JITC) who loves singing, traveling, WI sports, fitness, gaming, and cats. Views are my own.

[Andrea Kunz @dreandea]

Focusing on Value — 102 Things Journal Publishers Do (2018 Update) https://t.co/6KQ5x0UHax via @scholarlykitchn

[Andrea Kunz @dreandea]

This. "Capping the F&A cost rate at 15% indicates a fundamental misunderstanding of how biomedical research is conducted..." Read more: https://t.co/EBqceZZ1VI

[Zach Wahls @ZachWahls]

I had the opportunity this morning with Dr. George Weiner, a leading cancer researcher in our state, and Iowa pediatric cancer parents. It is past time for the legislature to appropriate dedicated funding to address Iowa’s cancer crisis!

[Andrea Kunz @dreandea]

@Basaraski I endured a similar situation at a Packers @ Vikings game a few years ago. Deplorable conduct and comments from the guys behind me, even going so far as to mess with my hair and hoodie. I spent the entire game trying to avoid calling attention to it, hoping the game would end.

[Jarushka Naidoo @DrJNaidoo]

Pleased to publish the largest study evaluating assoc btwn specific irAEs & IO outcomes @jitcancer:

- 9521pts in 14 atezo mono/combo trials
- G1-2 skin irAE, thyroid, pneumonitis assoc ⬆️OS p<0.05
- G3-4 pneu, colitis assoc ⬇️OS p<0.01

@OncoAlert #LCSM https://t.co/B5G1iOoqFF

[Andrea Kunz @dreandea]

It was wonderful to receive the Pedro Romero Service to #JITC Award at #SITC24 and celebrate with so many of the @sitcancer and JITC family. Thank you to everyone who has shared congratulatory messages throughout the meeting and beyond. I’m feeling quite blessed. ❤️

[Journal for ImmunoTherapy of Cancer @jitcancer]

New #JITC special series - SITC 40th Anniversary: I-O Progress and Potential.
Read the first article by #SITC24 Richard V. Smalley Award recipient Elizabeth Jaffee @DrLizJaffee @sitcancer https://t.co/vSIgCT9xrf

[Andrea Kunz @dreandea]

🐺🏀🍗 #packpix

[Journal for ImmunoTherapy of Cancer @jitcancer]

In honor of #PeerReviewWeek - Thank you to the many #JITC reviewers who support the advancement of cancer immunotherapy! 👏 ⭐ https://t.co/oLTOAB3TfF @sitcancer @sitcancerECS

[Andrea Kunz @dreandea]

Date night with the Glaucomfleckens!

[Dr. Glaucomflecken @DGlaucomflecken]

A+ marquee work. See you tonight Iowa City!

[Journal for ImmunoTherapy of Cancer @jitcancer]

LAST CALL! Today is the last day to submit your application to be part of the 2025 Class of the #JITC Peer Review Mentorship Program! Apply now: https://t.co/kTtJjzhoET @sitcancer @sitcancerECS

[Journal for ImmunoTherapy of Cancer @jitcancer]

Last month, we lost a giant. Among the many ways Dr. Weber influenced the field of I-O, he led by example as a #JITC editor, reviewer, author, and friend. Thank you to Luke et al for capturing his spirit and inspiration in #JITC: https://t.co/04vkf2qeL8

"Forever a kind person, witty and humorous but also direct with high expectations of those on whom he had placed them. To have received such expectations was an honor to many of us and only made us better as we strived to achieve the success he was guiding us toward."

@jasonlukemd @BernardAFox @MoffittNews @uscnorris @nyulangone @theNCI
@CureMelanoma @MelanomaReAlli @sitcancer @OmidHamidMD

[Journal for ImmunoTherapy of Cancer @jitcancer]

Now through September 19, we are collecting mentee applications for our third year of the #JITC Peer Review Mentorship Program! Apply today: https://t.co/kTtJjzhoET @sitcancer @sitcancerECS

[NWS Storm Prediction Center @NWSSPC]

Today is the 4 year anniversary of the most expensive thunderstorm event in modern US history, the August 10, 2020 Midwest Derecho. This story map takes an in-depth look at this historic event.https://t.co/eXGmscMpK5

[Journal for ImmunoTherapy of Cancer @jitcancer]

In the spirit of the #Olympics, we call this photo "Passing the Baton." Our new EIC, Michael Lotze, caught a shot with exiting Interim EIC, James Gulley (@gulleyj1), while out for a run. Such a #JITC power team! 🥇 🌟 🏃‍♂️ 👟
@PittTweet @theNCI @sitcancer @SU2C

[Andrea Kunz @dreandea]

@gulleyj1 @jitcancer Thanks, Dr. Gulley! Working with leaders like you is what makes the support I provide at JITC so rewarding!

[Journal for ImmunoTherapy of Cancer @jitcancer]

New #JITC Hypothesis: the generation of T cells directed against neoepitopes employing immune-mediating agents other than neoepitope vaccines https://t.co/FIaYh1oGFK @gulleyj1

[Andrea Kunz @dreandea]

@Moral_Wisdom_ Please note credit for the artist. It appears it has been cropped out.

[Scholarship for PhD @ScholarshipfPhd]

This is what great writing looks like:

[Journal for ImmunoTherapy of Cancer @jitcancer]

New #JITC article: Distinct host preconditioning regimens differentially impact the antitumor potency of adoptively transferred Th17 cells https://t.co/9XmBktIgfp @megen_wittling @GuillermoORang1 @LesinskiLab @PaulosLab

[Journal for ImmunoTherapy of Cancer @jitcancer]

New #JITC editorial: Perspectives from the leadership of Journal for ImmunoTherapy of Cancer https://t.co/vSE9njuEnw